What Are Clinical Trials for MASH? Clinical trials for MASH are research studies that evaluate potential new treatments for a form of liver disease called metabolic dysfunction-associated ...

Clinical trials are conducted in several phases to determine whether new treatments are safe and effective. The results from Phases 1, 2 and 3 inform the U.S. Food and Drug Administration (FDA) on ...

A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...

Clinical trials are the cornerstone of drug innovation in modern medicine, providing a systematic, evidence-based framework for determining the efficacy and safety of treatments before they reach ...

Clinical trial names span a broad range, from straightforward acronyms to more inspiring titles—see: Eli Lilly’s optimistically dubbed family of Triumph trials—to the downright ostentatious, like ...

With various challenges impacting the clinical supply chain, existing models are no longer fit-for-purpose and need to adapt.

Different groups of people—men, women, children, and people of different races or ethnic backgrounds—respond differently to different drugs. Clinical trials are supposed to drive advances in medicine ...

The integration of artificial intelligence (AI) and machine learning (ML) in oncology clinical trials is rapidly evolving alongside the broader field. For example, AI-driven adaptive trial designs may ...

In this video interview, Marc Buyse, ScD, founder and CEO of IDDI, examines the most common threats to trial data reliability, including opaque methodologies, synthetic controls, and the limits of ...